Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of sr9011 capsule in China. Welcome to wholesale bulk high quality sr9011 capsule for sale here from our factory. Good service and reasonable price are available.
SR9011 Capsule is an experimental compound that belongs to the Rev-Erb agonist category. It mainly functions on the circadian rhythm-regulating protein Rev-ErbAα/β. It was developed by the team of scientist Thomas Burris and is intended to regulate metabolism, inflammation, and circadian rhythms by activating the Rev-Erb pathway. In preclinical studies, SR9011 has shown significant effects, including promoting energy consumption, reducing fat accumulation, improving glucose metabolism, and possibly inhibiting the growth of tumor cells. Its mechanism of action involves inhibiting fat production, enhancing mitochondrial function, and regulating macrophage activity. Although the results from animal experiments are impressive (such as a 20% weight loss in mice without reducing their appetite), SR9011 has not yet completed human clinical trials and its safety and efficacy remain to be verified. Currently, it is only used for studying the circulation of chemicals and has not been approved for medical use. Potential side effects may include sleep disorders or cardiovascular effects. The capsule form is intended to enhance oral bioavailability, but the actual absorption rate still requires further research. The developers hope that it will be applied in the fields of metabolic diseases, cancer or inflammation treatment in the future.
|
|
|
SR9011 Powder COA
Safety observations in preclinical studies
SR9011 capsule, as a novel REV-ERBα/β agonist, demonstrates potential therapeutic value in regulating key physiological processes such as circadian rhythm, metabolism, and inflammatory responses. However, before advancing its clinical application, a comprehensive assessment of its long-term safety is of utmost importance. The following is a detailed analysis of the safety observations of SR9011 Capsule in preclinical studies.
Safety observation of metabolic-related indicators
In animal experiments, SR9011 regulates genes related to fat and glucose metabolism, inducing energy consumption and weight loss. However, long-term use of SR9011 may cause abnormal fluctuations in metabolic rate and increase the risk of uncontrolled blood sugar and lipid levels. For instance, experiments showed that although mice given SR9011 for a long time lost weight, some individuals experienced fluctuations in blood sugar and abnormal lipid levels. This suggests that when using SR9011 for a long time, it is necessary to closely monitor the blood sugar and lipid levels of patients to prevent the occurrence of metabolic disorders.
Safety assessment of circadian rhythm influence
SR9011, as a REV-ERBα/β agonist, has a significant impact on the circadian rhythm. It regulates circadian behavior by inhibiting the transcription factors BMAL1 and CLOCK. However, long-term intervention may disrupt the stability of the biological clock, leading to sleep disorders, hormonal secretion disorders, and abnormal immune function. In experiments with mice in constant darkness, SR9011 caused a decrease in running wheel behavior, and this inhibitory effect was dose-dependent. This indicates that long-term use of SR9011 may interfere with normal circadian rhythms, increasing the risk of sleep disorders and hormonal secretion disorders. Therefore, when using SR9011, its impact on the patient's circadian rhythm should be evaluated, and corresponding adjustment measures should be taken.
Safety Monitoring of Organ Toxicity
High-dose or long-term administration of SR9011 may cause hepatocyte necrosis, fatty liver, and renal tubular damage. Experimental data show that when SR9011 is used at a high dose, the drug and its metabolites deposit in the renal tubules, leading to hyperuricemia nephropathy, manifested as hematuria, proteinuria, and azotemia. Moreover, long-term use of SR9011 may also cause damage to the liver, resulting in hepatocyte necrosis and fatty liver. Therefore, when using SR9011 for a long time, it is necessary to regularly monitor the liver and kidney functions of patients, and detect and handle potential organ toxicity as early as possible.
Identification of Potential Risks and Side Effects
In addition to the aforementioned metabolic and organ toxicity risks, SR9011 may also cause other side effects. For instance, some experimental animals experienced digestive tract symptoms such as nausea, vomiting, and diarrhea after receiving SR9011 treatment. Long-term use may exacerbate damage to the gastrointestinal mucosa, increasing the risk of ulcers or bleeding. Moreover, although bone marrow suppression has not been directly reported, similar drugs may cause a decrease in white blood cells or platelets. Therefore, when using SR9011, it is necessary to closely monitor the patient's blood routine and digestive tract symptoms to promptly adjust the treatment plan.
Safety Considerations for Special Populations
For pregnant women, lactating women, patients with severe liver or kidney dysfunction, heart or lung diseases, or abnormal blood systems, the use of SR9011 should be carried out with extreme caution. These individuals, due to their special physiological conditions or underlying diseases, may have an increased sensitivity to SR9011, thereby increasing the risk of adverse reactions. Therefore, before using SR9011, a comprehensive assessment of the patient's condition is necessary to ensure medication safety.
Special Groups and Taboos
Safety considerations for special populations
Pregnant and lactating women
The animal experiments of SR9011 showed that it might deposit in fetal tissues through the placental barrier and be secreted into the infant's body through breast milk. Although human data is not yet clear, based on its mechanism of action (regulating metabolism and circadian rhythm), it may have potential effects on fetal development or the infant's physiological rhythm. Therefore, pregnant and lactating women should avoid using SR9011.
Children
Children are in the stage of growth and development, and their metabolic systems and organ functions are not yet mature. There is a lack of long-term safety data for SR9011 in children, and it may interfere with the secretion of growth hormone or bone development. Therefore, children should avoid using it.
Patients with severe liver and kidney dysfunction
SR9011 is mainly metabolized by the liver and excreted by the kidneys. Patients with severe liver and kidney dysfunction may experience drug accumulation due to slowed metabolism or excretion disorders, increasing the risks of hyperuricemia nephropathy, liver cell necrosis, etc. For example, animal experiments have shown that a high dose of SR9011 can cause renal tubular deposition and liver function abnormalities, suggesting that such populations should be prohibited from using it.
The elderly
The elderly often have multiple organ functional decline and increased sensitivity to drugs. SR9011 may aggravate metabolic disorders or circadian rhythm disorders, and should be used with caution and closely monitor liver and kidney function and electrolyte levels.
Contraindications and Potential Risks
Those allergic to SR9011 or its components
Allergic reactions may manifest as rashes, itching, breathing difficulties, or even anaphylactic shock, requiring immediate discontinuation of the medication and medical attention.
Patients with severe liver and kidney dysfunction
The liver is the main metabolic site for SR9011, and the kidneys are responsible for excretion. Liver dysfunction may lead to slowed drug metabolism, while kidney dysfunction may cause drug accumulation, both increasing the risk of toxicity. Animal experiments have shown cases of liver cell necrosis and renal tubular damage caused by high-dose SR9011, supporting this contraindication.
Patients with combined metabolic diseases or circadian rhythm disorders
SR9011 may exacerbate blood sugar fluctuations, lipid abnormalities, or sleep disorders. For example, experiments have shown that mice using SR9011 for a long time experienced blood sugar fluctuations and lipid abnormalities, suggesting that diabetic patients should use it with caution.
Risk of drug interaction
SR9011 may affect the concentration of other drugs by inducing metabolic enzymes (such as CYP450). When used in combination with antidepressants (SSRIs), hypoglycemic drugs, or anticoagulants, be vigilant of reduced efficacy or increased toxicity. For example, using it with warfarin may increase the risk of bleeding, and INR values need to be closely monitored.
Clinical Application Recommendations
Pre-medication assessment
Before medication administration, a comprehensive assessment of the patient's liver and kidney functions, metabolic status, and concurrent medication use is required. Pregnant women, lactating women, children, and those with severe liver or kidney dysfunction should be strictly prohibited from using the drug.
Monitoring indicators
For long-term use, regular monitoring of blood glucose, blood lipids, liver and kidney functions, and electrolyte levels is necessary. For patients with concurrent metabolic diseases or circadian rhythm disorders, enhanced symptom monitoring (such as sleep quality, blood sugar fluctuations) is required.
Dose adjustment
For the elderly or patients with mild liver or kidney dysfunction, the dose should be adjusted according to the creatinine clearance rate to avoid drug accumulation.
Patient education
Inform the patient of possible side effects (such as nausea, diarrhea, sleep disorders) and the risk of drug interactions, and emphasize the importance of following the doctor's instructions for medication use.
The SR9011 Capsule, as a research reagent, its analytical methods mainly cover aspects such as purity testing, structure verification, content determination, and stability studies. The following introduces it from three dimensions: analysis items, verification indicators, and specific methods:
Analysis items and verification indicators
Analysis items: include identification tests, impurity determination (limit or quantitative analysis), content determination (characteristic parameters and content/efficacy determination).
Verification indicators: cover specificity, accuracy, precision (repeatability, intermediate precision and reproducibility), detection limit, quantification limit, linearity, range and durability.
Specific analysis methods
Purity detection
High Performance Liquid Chromatography (HPLC): Through HPLC, impurities in SR9011 can be separated and detected, thereby evaluating its purity. This method has the characteristics of high sensitivity and high resolution, and is suitable for the purity detection of research-grade reagents.
Nuclear Magnetic Resonance Hydrogen Spectroscopy (1H NMR): 1H NMR can provide information on the chemical environment of hydrogen atoms in the SR9011 molecule. By comparing with the standard spectrum, the chemical structure can be verified, and the purity can be indirectly evaluated.
Structure verification
Mass Spectrometry (MS): MS can determine the molecular weight of SR9011, thereby verifying its molecular structure. By comparing the theoretical molecular weight with the actual measurement value, the correctness of the chemical structure can be confirmed.
Infrared Spectroscopy (IR): IR can detect chemical bonds and functional groups in the SR9011 molecule. By comparing with the standard infrared spectroscopy spectrum, the chemical structure can be further verified.
Content determination
Ultraviolet-Visible Spectrophotometry (UV-Vis): At a specific wavelength, the absorbance of SR9011 is proportional to its concentration. By measuring the absorbance, the content of SR9011 can be calculated. This method is simple to operate and fast, and is suitable for content determination.
High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS): Combining the separation ability of HPLC and the detection ability of MS, HPLC-MS can accurately determine the content of SR9011 and simultaneously detect impurities. This method has the characteristics of high sensitivity and high accuracy, and is suitable for content determination of research-grade reagents.
Stability study
Long-term stability test: Store SR9011 Capsule under specified conditions (such as -20℃), and take samples regularly to detect purity, content and impurities, etc., to evaluate its long-term stability.
Accelerated stability test: Accelerate the degradation process of SR9011 Capsule by increasing storage temperature or humidity, etc., so as to evaluate its stability in a shorter period of time. This method helps to predict the stability of the drug during storage and transportation.
Hot Tags: sr9011 capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale